194 related articles for article (PubMed ID: 38100921)
1. Catalpol attenuates osteoporosis in ovariectomized rats through promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis.
Chen S; Jin J; Xu Z; Han H; Wu L; Li Z
Phytomedicine; 2024 Jan; 123():155262. PubMed ID: 38100921
[TBL] [Abstract][Full Text] [Related]
2. Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity.
Meng J; Zhang W; Wang C; Zhang W; Zhou C; Jiang G; Hong J; Yan S; Yan W
Biochem Pharmacol; 2020 Jan; 171():113715. PubMed ID: 31751538
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 6 in preosteoclasts suppresses age- and estrogen deficiency-related bone loss by stabilizing estrogen receptor α.
Moon YJ; Zhang Z; Bang IH; Kwon OK; Yoon SJ; Kim JR; Lee S; Bae EJ; Park BH
Cell Death Differ; 2019 Nov; 26(11):2358-2370. PubMed ID: 30787391
[TBL] [Abstract][Full Text] [Related]
4. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
[TBL] [Abstract][Full Text] [Related]
5. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
[TBL] [Abstract][Full Text] [Related]
7.
Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
[TBL] [Abstract][Full Text] [Related]
8. Effect of
Heo J; Kim M; Kim JH; Shin H; Lim SE; Jung HS; Sohn Y; Ku J
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297038
[TBL] [Abstract][Full Text] [Related]
9. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
[TBL] [Abstract][Full Text] [Related]
10. Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway.
Xiong Y; Huang CW; Shi C; Peng L; Cheng YT; Hong W; Liao J
Exp Biol Med (Maywood); 2023 Dec; 248(23):2363-2380. PubMed ID: 38240215
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine, a
Luo N; Zhang L; Xiu C; Luo X; Hu S; Ji K; Liu Q; Chen J
Food Funct; 2024 Feb; 15(4):2154-2169. PubMed ID: 38311970
[TBL] [Abstract][Full Text] [Related]
12. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
[TBL] [Abstract][Full Text] [Related]
13. Effect of Menaquinone-4 on Receptor Activator of Nuclear Factor
Lee AS; Sung MJ; Son SJ; Han AR; Hong SM; Lee SH
J Med Food; 2023 Feb; 26(2):128-134. PubMed ID: 36724309
[TBL] [Abstract][Full Text] [Related]
14. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
[TBL] [Abstract][Full Text] [Related]
16. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
17. Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.
Kim EY; Kim JH; Kim M; Park JH; Sohn Y; Jung HS
J Ethnopharmacol; 2020 Jul; 257():112828. PubMed ID: 32268206
[TBL] [Abstract][Full Text] [Related]
18. Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
Yuan SG; Hu HL; Wang XJ; Yang JC; Zhou RP; Bai XC; Lai PL
Orthop Surg; 2022 Jun; 14(6):1203-1216. PubMed ID: 35470579
[TBL] [Abstract][Full Text] [Related]
19. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
[No Abstract] [Full Text] [Related]
20. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
